Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
We are happy to announce Peter Graham is joining us as director of sales for the Western zone. He is responsible for achieving the company’s medical device sales in the region and will work with distributor organizations, target end-users, IDNs, and Government Purchasing Organizations.
Graham has extensive experience in sales selling clinical ai for radiology for earlier diagnosis and ai-powered tools for the workflow to clinical and administrative healthcare professionals. He is experienced in identifying new market opportunities and developing strategies.
He earned his B.S degree in mechanical engineering from the Clarkson University.